All In MedTech

FDA Clearance Tracker · P950032-S034

APLIGRAF

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Oct 15, 2002 (this decision)Source: openFDAMethods & limitations

PMA supplement

Decided

Oct 15, 2002

Approved

Time to decision

71 days

Received Aug 5, 2002. Calendar days, including time FDA spent waiting on the applicant.

Pathway

PMA supplement

Normal 180 Day Track

Device class

Class III

The decision

FDA number
P950032-S034
Device name
APLIGRAF
Applicant location
Canton, MA
Received
Aug 5, 2002
Decided
Oct 15, 2002
Decision
Approved
Supplement type
Normal 180 Day Track
Reason for supplement
Process Change - Manufacturer/Sterilizer/Packager/Supplier
Original approval
P950032

Device type

Device class
Class III

Every decision under product code MGR

FDA's approval statement

As written in FDA's record.

APPROVAL FOR THE INTRODUCTION OF A SODIUM HYDROXIDE STEP INTO THE BOVINE COLLAGEN PRODUCTION METHOD AND THE DISCONTINUATION OF VIRAL TESTING ON INDIVIDUAL LOTS OF COLLAGEN.

Source documents

Other decisions for Organogenesis, Inc.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.